baber/WOPTO huggingface dataset:
Patent AU-2021254653-B2 (AU)
Title: Novel compounds useful as potassium channel openers
Inventor: Bös Michael
IPC: A61P27/16
Filed: 2021-10-22
Granted: 2022-12-08
Abstract: The present invention discloses novel compounds which are useful as potassium channel 
openers, in particular as openers of the Kv7.4 potassium channel. The novel compounds are 
compounds according to formula I, 
0 
wherein 
-n = 0 or 1, 
- RL is a substituent selected from the group consisting of unsubstituted or 
substituted cycloalkyl groups, in particular bicycloalkyl groups, unsubstituted or 
5 substituted phenyl groups, unsubstituted or substituted thienyl groups or 
cyclopentathienyl groups, and unsubstituted or substituted indanyl groups, 
which optionally contain heteroatoms, and 
- RR is a substituent selected from the group consisting of unsubstituted or 
substituted phenyl groups or unsubstituted or substituted benzyl groups, which 
0 optionally contain heteroatoms, 
- or a stereoisomer, a tautomer, a prodrug or a salt, preferably pharmaceutically 
acceptable salt thereof.  
15
Patent AU-2021277548-B2 (AU)
Title: Fastening of a mirror to a support
Inventor: CASTEL DIDIER
IPC: G02B7/183
Filed: 2021-05-11
Granted: 2022-12-15
Abstract: A system for fastening a mirror (2) to a support (1) comprises intermediate structures (3), for example bipod structures. At least some of the intermediate structures are provided with torsion devices making it possible to at least partially compensate for the optical aberrations of an instrument that comprises the mirror. Each torsion device may comprise an elastic element (4) and a variable control (5). The variable control is designed to control the deformation of the elastic element, resulting in a torsional moment that is applied to the mirror.
Patent AU-2021282462-B2 (AU)
Title: Treatment of mitochondrial diseases
Inventor: MARTÍ SEVES RAMON
IPC: A61K31/7052
Filed: 2021-12-08
Granted: 2023-10-05
Abstract: The present invention provides a composition comprising one or more 
deoxyribonucleosides for use in the treatment of a mitochondrial DNA depletion 
and/or multiple deletions syndrome provided that the syndrome is not caused by a 
defect in the deoxyribonucleoside triphosphate (dNTP) metabolism. With the use 
of the invention there is a recovery in mitochondrial DNA levels independently 
from the severity of the patient's disease, which confers a great therapeutic value 
to the invention.
Patent AU-2022201863-B2 (AU)
Title: Method of making lipids with improved cold flow properties
Inventor: SUN ZHIYONG
IPC: C12P7/64
Filed: 2022-03-17
Granted: 2023-07-13
Abstract: OF THE DISCLOSURE 
Provided herein are methods of producing oils with reduced saturated fatty acids. The 
methods include culturing oil-producing microorganisms in a fermentation medium in the 
presence of one or more antifoaming agents under a controlled carbon consumption rate, 
wherein the culturing produces oils comprising fatty acids and wherein less than 35% of the 
fatty acids in the oil are saturated fatty acids.
Patent AU-2022204107-B2 (AU)
Title: Doped region structure and solar cell comprising the same, cell assembly, and photovoltaic system
Inventor: CHEN GANG
IPC: H01L31/068
Filed: 2022-06-13
Granted: 2023-10-05
Abstract: DOPED REGION STRUCTURE AND SOLAR CELL COMPRISING THE 
SAME, CELL ASSEMBLY, AND PHOTOVOLTAIC SYSTEM 
ABSTRACT 
The disclosure relates to the technical field of solar cells, and provides a solar cell and 
a doped region structure thereof, a cell assembly, and a photovoltaic system. The 
doped region structure includes a first doped layer, a passivation layer, and a second 
doped layer that are disposed on a silicon substrate in sequence. The passivation layer 
is a porous structure having the first doped layer and/or the second doped layer inlaid 
in a hole region. The first doped layer and the second doped layer have a same doping 
polarity. By means of the doped region structure of the solar cell provided in the 
disclosure, the difficulty in production and the limitation on conversion efficiency as a 
result of precise requirements for the accuracy of a thickness of a conventional 
tunneling layer are resolved.  
43
1/5 
Ono 00 5 no 5 no 0 0505 1 
FIG. 1 
v v v40 
vv -I a 
-- - - - - - - - - ---r -- - ---- - - --1 
...-. 1.r.-r ..:.. ..........-.. .  
. . . . .... .I .........-r ..a e , ee a r .. .  
e e . . . ... . . . . . ..-. . . . . ..- e a e e r a e e 
...... ..................> 20.  
. ........3 ........5 0. .. .  
70.. . .. . 60...  
-- -----------------F- --G .- -- 2
Patent AU-2022263518-B2 (AU)
Title: Method and computing environment for creating and applying a test algorithm for computational processes
Inventor: SCHALLENBERG ANDREAS
IPC: G06F11/36
Filed: 2022-11-02
Granted: 2023-09-07
Abstract: Method and computing environment for creating and applying a 
test algorithm for computational processes 
The subject matter of the invention is a method for computer
assisted creation of a test algorithm for processing 
applications in a computing environment (RU) for executing a 
large number of application programs, by taking into account 
configuration data (KD) for the application programs. For each 
application program, a data segment (DA) is formed and the 
configuration data (KD) referring to the relevant application 
program is combined as a data segment (DA). The data segments 
are combined in a data set (DS). A global ID code is assigned 
to the data set. Participating components of the computing 
environment (RU) are identified, and an ID code assigned to 
them. A hash function is applied to each of the data segments 
contained in the data set. A calculation function is applied 
to each data segment in that the ID codes, the hash value of 
the relevant data segment and the global ID code are linked 
together by computational operators. From this, a test 
function is created for each data segment, which can be 
applied for monitoring in a method for computer-assisted 
processing of applications in a computing environment. A 
safety-relevant computing environment (RU), a computer program 
product and a provisioning apparatus for these are also 
subject matter of the invention.  
Fig 3
1/4 
FIGi1 
RU 
HS3 S3 STWs 
S8S 
S8 GL 
0 LS 
S9-,,__ WH & 
C 
- -
GL 
WA 
BL
Patent JP-4643792-B2 (JP)
IPC: H01M14/00
Filed: 2000-03-31
Granted: 2011-03-02
Abstract: A photoelectric conversion device having a conductive support, a photosensitive layer containing a semiconductor, a charge transfer layer containing an electrolyte composition, and a counter electrode, wherein the electrolyte composition comprises 0.01 to 2.5 weight % of a metal cation, and 1 to 30 weight % of SCN<-> and/or an anion represented by the following general formula (1): Rf-COO<-> wherein Rf represents an alkyl group substituted by at least one fluorine atom. The photoelectric conversion device exhibits high durability and excellent photoelectric conversion properties, and can be used for a photo-electrochemical cell.
Patent JP-4233742-B2 (JP)
IPC: A61B17/32
Filed: 2000-10-05
Granted: 2009-03-04
Abstract: The present invention relates to ultrasonic surgical clamping instruments and, more particularly, to a curved clamp arm tissue pad attachment for use with ultrasonic surgical instruments. A curved clamp arm for use with an ultrasonic surgical instrument is described. The curved clamp arm includes a proximal end and a distal end, with a top surface extending from the proximal end to the distal end of the curved clamp arm. The top surface comprises at least one hole. The clamp arm includes a bottom surface opposite the top surface, with the bottom surface extending from the proximal end to the distal end of the clamp arm. The bottom surface includes at least one engaging surface, where the hole in the top surface extends from the top surface to the engaging surface of the clamp arm. One embodiment of the curved clamp includes a plurality of the holes in the top surface, and a plurality of the engaging surfaces in the bottom surface, wherein each hole in the top surface extends through the curved clamp arm, terminating at a corresponding engaging surface on the bottom surface. The plurality of holes may also be staggered laterally from the proximal end of the clamp arm to the distal end of the clamp arm.
Patent JP-3995413-B2 (JP)
IPC: A61B17/03
Filed: 1998-09-14
Granted: 2007-10-24
Abstract: The instrument consists of at least one tube (2) which can be introduced into the patient's body through a percutaneous access point close to the soft tissues (M1, M2) to be joined. The tube contains two elongated components (4) with distal ends (10a) able to grip the two soft tissue sections and draw them together so they can be joined by a fixing. The mobile elongated components and fixings (20, 22) are controlled from outside the patient's body, with the elongated components having a system (10, 11) which allows them to be deployed and active or retracted and inactive. Their tips can be barbed in the form of harpoons, and the fixings can be staples.
Patent JP-3600158-B2 (JP)
IPC: A61N1/30
Filed: 1999-05-11
Granted: 2004-12-08
Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.
Patent JP-4800480-B2 (JP)
IPC: C09D151/06
Filed: 1999-06-30
Granted: 2011-10-26
Abstract: The invention relates to solvent-based primer compositions containing 0.5 to 40 weight percent of a modified polyolefin and a solvent selected from the group consisting of ester solvents, ketone solvents, aliphatic solvents, aromatic solvents and mixtures thereof. The modified polyolefin is formed from an amorphous polyolefin selected from polypropylene and a propylene copolymer or a propylene terpolymer or an ethylene copolymer or terpolymer. Preferably the polyolefin is a polypropylene copolymer or terpolymer containing about 1 to about 99 mole percent ethylene, 1-butene, 1-pentene, and 1-hexene. The amorphous polyolefin has a number average molecular weight ranging from about 1,000 to 15,000 and is chemically modified with one or more unsaturated carboxylic acids selected from the group consisting of acids, esters and anhydrides. These primers are useful for significantly improving the adhesion of paints to polyolefin surfaces.
Patent JP-5053483-B2 (JP)
IPC: G06Q30/02
Filed: 1999-07-27
Granted: 2012-10-17
Abstract: A computer system for automatic replacement of advertisements includes an advertising server for selecting an advertisement based on criteria related to the individual viewer. In particular, advertisements are selected for a given user, based on the past behavior of that specific given user. Advertiser web sites on the network are configured to anonymously report back user activity such as visit dates, purchases, specific product pages visited and the like. Alternative reporting embodiments include email, file transfer protocol and spotlight tags. User activity lists are processed to select candidates for re-targeting. Candidates for re-targeted advertisements are identified based on their own individual past activity, and stored in a list of candidate user ID's. When a candidate on the re-targeted list is identified at any network affiliate web site, a re-targeted advertisement is delivered to the candidate user.
Patent JP-4237413-B2 (JP)
IPC: C12R1/38
Filed: 1999-10-29
Granted: 2009-03-11
Abstract: Relating to an enzyme capable of efficiently converting a ketone compound to an optically active amino compound by transamination, and a process for preparing an optically active amino compound using the enzyme. An (S)- alpha -phenethylamine : pyruvate transaminase, which acts on (S)- alpha -phenethylamine and a ketone compound, thereby catalyzing transamination for forming acetophenone and an amino compound corresponding to the ketone compound; a process for preparing an optically active amino compound using the transaminase; and a method for culturing a microorganism for producing the above transaminase, comprising adding to a medium one or more compounds selected from the group consisting of propylamine, 1-butylamine, 2-butylamine, 2-pentylamine, isopropylamine and isobutylamine as an inducer for the enzyme when a microorganism for producing (S)- alpha -phenethylamine : pyruvate transaminase is cultured.
Patent JP-3905312-B2 (JP)
IPC: A61B3/13
Filed: 1999-11-23
Granted: 2007-04-18
Abstract: The invention is a low cost, low input power eye viewing device well suited for viewing wide field retinal images through an undilated pupil. Included in the device are a converging light illumination system and an aperture stop. The converging light illumination system provides ease of entry of light rays into an eye, wide field retinal illumination, reduced glare and reduced power consumption. The aperture stop blocks unwanted received glare light not forming part of the retinal image. The device is made especially well suited for retinal viewing through an undilated pupil if the aperture is sized in accordance with the diameter of an undilated pupil.
Patent JP-4822586-B2 (JP)
IPC: C02F/
Filed: 2000-02-24
Granted: 2011-11-24
Abstract: The present invention relates to novel agropolymers, which comprise a carbohydrate and/or silica matrix substantially devoid of proteins, tannins and polyphenols and which comprise metal binding reactive sites. A method of producing the agropolymers is also disclosed wherein the agropolymers are derived from plant materials such as seed coats, seed covers, husks, or hulls of various agricultural crops. The agricultural crops typically used to produce the agropolymers include Oryza sativa, Panicum miliaceum, Setaria italica, Cajanus cajan, Vigna mungo, Vigna radiata, Triticum sp., Ricinus communis, Helianthus annus, Gossypium sp., and Arachis sp. The agropolymers of the present invention are capable of purifying aqueous solutions polluted or contaminated with metals and/or ions. Thus, the present invention also discloses a method whereby agropolymers are used in the purification of contaminated water and other aqueous solutions. The agropolymers disclosed herein are useful in several industrial applications including purifying polluted drinking water or ground water.
Patent JP-4641100-B2 (JP)
IPC: C12P13/12
Filed: 2000-03-28
Granted: 2011-03-02
Abstract: Hydantoinase enzymes are mutants of a previously isolated hydantoinase having the amino acid SEQ. ID. NO. 2. The mutants include amino acids substitutions at positions (95, 154, 180, 251 and/or 255) of the wild type hyndantoinase (SEQ. ID. NO. 2). The mutant hydantoinases, like the parent hydantoinase, are used in the production of optically pure amino acids.
Patent JP-5379934-B2 (JP)
IPC: C23C28/04
Filed: 2000-03-31
Granted: 2013-12-25
Abstract: The invention relates to a coated component, in particular a coated tool for machining, having a substrate and a first carbon layer, which is applied to the substrate and has a predetermined fraction of carbon with a diamond crystal structure. There is the problem with such a component that the adhesive strength of the first carbon layer on the substrate is unsatisfactory in many instances. This problem is solved by virtue of the fact that provision is made of a second carbon layer, which is arranged further outside with reference to the substrate than the first carbon layer, and in the case of which the fraction of carbon with a diamond crystal structure is lower than the predetermined fraction of carbon with a crystal diamond structure in the first carbon layer. The invention also relates to a process for producing such a coated component.
Patent JP-3843012-B2 (JP)
IPC: A61K31/405
Filed: 2000-10-17
Granted: 2006-11-08
Abstract: Compounds of the formula I are suitable for preparing pharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of NFkappaB is involved.
Patent JP-4602623-B2 (JP)
IPC: C12M1/34
Filed: 2000-12-21
Granted: 2010-12-22
Abstract: The present invention provides a method of manufacturing a micro-titer test plate comprising a plurality of sample containers (10) connected to each other of which each sample container (10) has one or more side walls enclosing the interior of said sample container, a bottom wall with an outlet opening and an opposite upper end that is open and defines an inlet opening (14), said method comprising the steps of:   providing a first (60,61,110,120) and second part (50,80,200), said first part (60,61,110,120) comprising a plurality of wells (30,115,125) connected to each other and each having an upper end that is open and that will define the inlet opening (14,114,124) of said sample containers (10) and an opposite bottom opening (16,116,126) and said second part (50,80,200) comprising a plurality of spouts (24) connected to each other, said spouts (24) conforming in arrangement and number to said wells (30,115,125) of said first part (60,61,110,120) and each spout (24) enclosing at a first end (23,201) an opening (22,202) that will define the outlet opening of said sample containers (10), and each spout (24) optionally having an upper opening (55) at said first end (23) for receiving a filter means (39); placing a filter sheet (1,5) that extents across each of said wells (30,115,125) of said first part (60,61,110,120) on one side of said first part or placing a filter sheet (1,5) that extends across each of said spouts (24) of said second part (50,80,200) on the side of said second part having said first ends (23,201); separating from said filter sheet (1,5) filter means (39) that conform in shape, size, arrangement and number to either the bottom opening (16,116,126) of the wells of said first part (60,61,110,120) or when present, to said optional upper openings (55) provided at the first end (23,201) of the spouts (24); placing said filter means (39) in each of the bottom openings (16,116,126) of the wells or when present in each of said upper openings (55) provided at the first end (23,201) of the spouts (24); removing the remainder of said filter sheet (1,5) from which the filter means (39) have been separated; bringing said first part (60,61,110,120) and said second part (50,80,200) in contact with each other such that the bottom opening (16,116,126) of said wells face the first end (23,201) of said spouts (24); and bonding said first part (60,61,110,120) and said second part (50,80,200) to each other by permanently and irreversibly bonding each of the wells (30,115,125) of said first part (60,61,110,120) to each of the spouts (24) of said second part (50,80,200) thereby forming a plurality of sample containers (10) connected to each other that are sealed with respect to each other.   <IMAGE>
Patent JP-4234934-B2 (JP)
IPC: H01L21/68
Filed: 2002-02-15
Granted: 2009-03-04
Abstract: <P>PROBLEM TO BE SOLVED: To provide an unmanned conveying cart system which does not need to prepare different conveying carts for each size and can convey wafers having different sizes by the same conveying cart even when the wafers having the different sizes are mixed in a same manufacturing line.  <P>SOLUTION: An unmanned conveying cart 2 is provided with a leaf transfer device 18 for transferring a wafer, a buffer cassette 17a for housing the wafer and a controller 12 of the leaf transfer device 18. The buffer cassette is mounted on a conveying card body 5 detachably, and different transfer operation programs for each size of the wafer housed in the buffer cassette to be mounted are stored in the controller 12. A detection mechanism for detecting a difference in a mounting plane shape of the buffer cassette to be mounted is provided, and the controller 12 is arranged to operate a holding mechanism in response to the buffer cassette mounted based on detection results of the detection mechanism.  <P>COPYRIGHT: (C)2003,JPO
Patent JP-3875180-B2 (JP)
IPC: H04B/
Filed: 2002-11-08
Granted: 2007-01-31
Abstract: The present invention discloses a communication station for communicating with a second station in a cellular-communication network using spread spectrum modulation wherein the second station transmits power commands to the communication station based on a received power level from the communication station, the communication station comprising: a transmitter having an adjustable transmitter power level for transmitting spread-spectrum signals; means for sequentially receiving power commands from a second station with which communication is being conducted; means for comparing a sequence of at least two of the received power commands to determine if the received commands in the sequence match; and means for adjusting the transmitter power level at a same rate as the reception of the power commands; wherein if the command sequence matches the transmitter power level is adjusted by a different amount than if the command sequence does not match. A method for adjusting a transmitter power level is also disclosed.
Patent JP-4297682-B2 (JP)
IPC: H01L21/60
Filed: 2002-11-26
Granted: 2009-07-15
Abstract: Devices that have bonding pads, and methods for fabricating the same. The bonding pads have two conductive layers, and an intermediate layer between them. The intermediate layer has a hybrid configuration of a relatively large conductive plate section, and a mixed plugs/mesh section. The plugs/mesh section has conductive portions interspersed with non-conducting portions, with features that are relatively small in size. The hybrid configuration achieves a proper balance between the plate section for the main electrical contact, and the plugs/mesh section for support and additional current density.
Patent JP-5053499-B2 (JP)
IPC: A61P25/28
Filed: 2001-06-29
Granted: 2012-10-17
Abstract: A pharmaceutical for prevention and treatment of demyelination-associated neural function impairing diseases, the pharmaceutical containing erythropoietin as an active ingredient, and a method for prevention and treatment of the diseases are provided. The preventive and therapeutic pharmaceutical and method of the present invention protectively act on the survival of oligodendrocytes, which form a myelin sheath, in cerebrovascular dementia typified by multiple sclerosis and Binswanger disease, diseases involving demyelination. The pharmaceutical and method also promote maturation of undifferentiated oligodendrocytes present in the brain, activating remyelination. Through these mechanisms, the pharmaceutical and method can prevent and treat demyelination-associated neural function impairing diseases. <IMAGE>